The pathophysiologic vulnerability of the subendocardium of the left ventricle.
D001145:Arrhythmias, Cardiac / Q000209:etiology; D002196:Capillaries / Q000502:physiology; D006332:Cardiomegaly / Q000503:physiopathology; D003327:Coronary Disease / Q000209:etiology* / Q000503:physiopathology; D003331:Coronary Vessels / Q000503:physiopathology; D004699:Endocardium / Q000098:blood supply*; D006352:Heart Ventricles / Q000098:blood supply*; D006801:Humans; D000860:Hypoxia / Q000150:complications; D007545:Isoproterenol / Q000494:pharmacology; D008729:Methoxamine / Q000494:pharmacology; D008833:Microcirculation; D008944:Mitral Valve Insufficiency / Q000209:etiology; D009203:Myocardial Infarction / Q000209:etiology / Q000503:physiopathology; D009206:Myocardium / Q000378:metabolism; D009336:Necrosis / Q000209:etiology; D005996:Nitroglycerin / Q000494:pharmacology; D010101:Oxygen Consumption; D010210:Papillary Muscles / Q000503:physiopathology; D011433:Propranolol / Q000494:pharmacology; D012039:Regional Blood Flow
D011433:Propranolol; D005996:Nitroglycerin; D008729:Methoxamine; D007545:Isoproterenol